The Potential Dangers of Ketogenic Diets in Kidney Disease
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
Type 1 Diabetes Information Center
Burden of Depressive Symptoms High in T1D, T2D in Developing Countries
The researchers evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from an international study to glean information about people in developing countries.
Diabetes Cost-of-Care Conversations Needed in Primary Care
Diabetes is one of the most expensive chronic diseases, yet few patients discuss cost-of-treatment with their primary care physicians.
Cardiorenal Disease Burden Increased in Type 1 Diabetes Across Lifespan
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Regularly Monitoring Glucose and Using Insulin Pump Lowers HbA1c in Juvenile Type 1 Diabetes
Although different insulin analogs, pumps, and sensors have been proven to work, studies have shown that few children and adolescents achieve recommended HbA1c targets.
98% of Parents Would Screen Children for T1D if Tests Were Free
Physicians and parents have ranked important features of conducting type 1 diabetes screening tests, which is crucial due to the increasing prevalence of type 1 diabetes in children.
Ophthalmologic Care Crucial for Women With T1D Before and During Pregnancy
The researchers assessed the rate of diabetic retinopathy progression in pregnant women with type 1 diabetes and its predictors.
Glycemic Control in Type 1 Diabetes Improved During Lockdown
Decrease in alcohol consumption, easier diabetes control perception were factors associated with better glycemic control
Nephropathy Progression in Type 1 Diabetes Linked to Depression
Whether successful treatment of depression reduces the risk for progression needs to be determined.
Diabetic Ketoacidosis Rates in Children With New T1D Diagnosis During COVID-19
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
Depression Screening in Type 1 Diabetes Pediatric Patients
Researchers implemented an electronic medical record-based depressive symptom screen in type 1 diabetes mellitus adolescents seen in an outpatient clinic.
Using Smartphone Apps for Glycemic Control in Diabetes: What Improvements Are Still Needed?
Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.
Recommendations for Effective Implementation of Telehealth for Diabetes Care
Experts provide recommendations for effective implementation of telehealth for diabetes care, with a focus on patient-to-clinic video encounters.
An Overview of CMS Interim Coverage for Telehealth, Diabetes Care During the COVID-19 Pandemic
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
Diabetes and COVID-19: Clinical Considerations and Recommendations
In the COVID-19 pandemic, there are specific considerations that should be made for patients with diabetes, who are at greater risk for severe infection.
Rotavirus Vaccination, Type 1 Diabetes Not Linked in Children
No significant correlation seen for children fully or partially exposed to rotavirus vaccine vs unexposed.
2002 to 2015 Saw Increase in Incidence of Diabetes in Youth
Incidence of type 1, type 2 diabetes increased; rates of increase higher in racial/ethnic minorities.
Screening for T1DM in Children May Help Reduce Morbidity
Public health screening of 2- to 5-year-olds revealed an islet autoantibody prevalence of 0.31%.
Telemedicine Visits Comparable for Glycemic Control in T1DM
Telemedicine instead of office visit did not change outcomes in patients with suboptimal glycemic control.
Fiasp Approved for Pediatric Patients With Diabetes
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 1 Diabetes Information Center
Loading... 
Loading...